Hospital Clinic De Barcelona
- Address
- lock Available on a paid plan
Eye Diseases
At Hospital Clinic De Barcelona the Retina department concentrates on eye diseases including diabetic macular edema, diabetic retinopathy and macular edema secondary to retinal vein occlusion, with trials designed to test innovative injection therapies and novel delivery approaches to preserve or improve visual acuity.
- Advanced anti‑VEGF injection strategies
- Suprachoroidal drug delivery platforms
- Topical agents for non‑proliferative diabetic retinopathy
- Safety comparisons of intravitreal treatments
These studies aim to enhance treatment effectiveness and safety for patients facing vision‑threatening conditions, supporting the site’s commitment to advancing retinal care.
Respiratory Tract Diseases
In addition to ocular work, the centre conducts research on respiratory tract diseases, specifically bronchiectasis complicated by chronic Pseudomonas aeruginosa infection, evaluating new antibody therapies to reduce bacterial burden and improve lung function.
- Antibody treatment targeting Pseudomonas
- Strategies for chronic bronchiectasis management
- Biomarker monitoring of sputum bacterial load
- Long‑term safety of novel inhaled agents
The goal is to provide more effective options for patients with persistent airway infections, ultimately aiming to enhance quality of life and respiratory health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 33 therapeutic areas and 15 of 1 000 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 939 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 236 by active trials.
- 1AstraZeneca AB26active
lock +235 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB56trials
lock +125 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Clinic De Barcelona
lock Showing 1 of 1 049 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (22153) Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion | Bayer AG | Phase III | Not Recruiting | Sep 2023 | May 2025 |
IMP list
lock Showing 1 of 1 000 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 74 | Unknown | 2015-07-16 | 2026-08-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.